aka NN9838 · CagriSema component
Open any panel for the full data
Cagrilintide is a long-acting analog of amylin, a hormone co-secreted with insulin that regulates satiety. It is being developed by Novo Nordisk, both as monotherapy and in combination with semaglutide (CagriSema). Phase 2 trials have shown promising weight loss results.
Third-party creator videos and discussion, surfaced for research context. Amino Axiom does not endorse creator claims.
Peptide: Cagrilintide
What Is Cagrilintide? How It Works + Why It Pairs With Retatrutide
your GLP-1 results will stall without this one thing 👇 resistance training 💪 not walking not yoga not “staying active” lifting heavy thing
I need you to hear this 👇 if you’ve been told your whole life that you just need more discipline, more willpower, more motivation — that wa
true GLP-1 non-response is actually rare 🧬 clinical data suggests it’s only a small fraction of patients. so if your medication “stopped wo